- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KL-02-0048138

Sainbaxy Labs Private Limited
About Sainbaxy Labs Private Limited
Data last updated:
Sainbaxy Labs Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 07 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2018PTC053575. Its GSTIN is 32ABACS4285R1ZT (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Vazhappully Karvarnan Greeshma and Nibin Xavier.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Parappilly House Elamakkara P.O, Kochi, Kerala, India – 682026.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.88 Lakh, a growth of 116% compared to the previous year. For the same year it recorded a net profit of ₹4.22 Lakh (net margin 4.4%) and EBITDA of ₹6.15 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 146% over three years and 91% over five years.
Sainbaxy Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0048138).
Company details
Recognitions & Rankings of Sainbaxy Labs
Contact details
Sainbaxy Labs Private Limited's registered office is in Kochi, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressParappilly House Elamakkara P.O, Kochi, Kerala, India – 682026
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Sainbaxy Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sainbaxy Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sainbaxy Labs Private Limited, buy the company report.
Financials of Sainbaxy Labs Private Limited
FY 2025 filings availableSainbaxy Labs Private Limited reported revenue of ₹96.88 Lakh (up 116% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 116% growth in the latest year. EBITDA rose 459% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sainbaxy Labs Private Limited, buy the company report.
Board of directors of Sainbaxy Labs Private Limited
Sainbaxy Labs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vazhappully Karvarnan Greeshma | Director | 07 Dec 2023 | 2 Years 10 Months | Current |
| Nibin Xavier | Director | 07 Jun 2018 | 8 Years 4 Months | Current |
| Sukumaran Sumod Also directs: Tamlur Builders Private Limited, NRD Healthcare Private Limited | Director | 07 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Sainbaxy Labs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auriga Laboratories Private Limited | ₹97.25 Lakh (FY 2024) | 62.0% | Delhi, India | |||
| Umr Laboratories Private Limited | ₹97.2 Lakh (FY 2025) | 67.0% | Hyderabad, Telangana, India | |||
| Aquasis Water Treatment Technologies Private Limited | ₹97.16 Lakh (FY 2023) | 14.0% | Neyyattinkara, Kerala, India | |||
| Mitawa Calcium and Minerals Private Limited | ₹97.11 Lakh (FY 2025) | 4.0% | Jodhpur, Rajasthan, India | |||
| Malda Container Industries Private Limited | ₹96.91 Lakh (FY 2023) | Malda, West Bengal, India | ||||
| Sainbaxy Labs Private Limitedthis company | ₹96.88 Lakh (FY 2025) | ₹4.22 Lakh | 4.4% | 116.0% | Kochi, Kerala, India | |
| Saara Polycoats Private Limited | ₹96.85 Lakh (FY 2016) | 14.0% | Pune, Maharashtra, India | |||
| Merit Treatment Chemicals Private Limited | ₹96.84 Lakh (FY 2023) | Vasai, Maharashtra, India | ||||
| Euro Pesticides Private Limited | ₹96.76 Lakh (FY 2025) | -11.0% | Kurukshetra, Haryana, India | |||
| Lepius Life Sciences Private Limited | ₹96.74 Lakh (FY 2025) | -22.0% | Ahmedabad, Gujarat, India | |||
| Honor Applied Materials Private Limited | ₹96.65 Lakh (FY 2024) | -4.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Sainbaxy Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sainbaxy Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sainbaxy Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sainbaxy Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32ABACS4285R1ZT | Kerala | Active | 07 Jul 2018 |
To see the full GST registrations and return filing status of Sainbaxy Labs Private Limited, buy the company report.
Recent activity
Sainbaxy Labs Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Vazhappully Karvarnan Greeshma was appointed as Director on 07 Dec 2023.
Frequently asked questions
Sainbaxy Labs is an active private limited company based in Kochi, Kerala, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 07 June 2018 (8+ years old) and is registered under CIN U74999KL2018PTC053575.
Sainbaxy Labs has 3 current directors:
- Vazhappully Karvarnan Greeshma - Director
- Nibin Xavier - Director
- Sukumaran Sumod - Director
The latest financial statements of Sainbaxy Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Sainbaxy Labs is 32ABACS4285R1ZT, registered in Kerala.
The CIN (Corporate Identification Number) of Sainbaxy Labs is U74999KL2018PTC053575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sainbaxy Labs was incorporated on 07 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Sainbaxy Labs by revenue are Auriga Laboratories Private Limited, Umr Laboratories Private Limited, Aquasis Water Treatment Technologies Private Limited, Mitawa Calcium and Minerals Private Limited, Malda Container Industries Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vazhappully Karvarnan Greeshma was appointed as Director on 07 Dec 2023. Nibin Xavier was appointed as Director on 07 Jun 2018. Sukumaran Sumod was appointed as Director on 07 Jun 2018.
Yes, Sainbaxy Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0048138).
The registered office of Sainbaxy Labs is at Parappilly House Elamakkara P.O, Kochi, Kerala, India – 682026.
Sainbaxy Labs operates in the business services industry, in the miscellaneous business activities segment.